JP2024512791A5 - - Google Patents

Info

Publication number
JP2024512791A5
JP2024512791A5 JP2023561034A JP2023561034A JP2024512791A5 JP 2024512791 A5 JP2024512791 A5 JP 2024512791A5 JP 2023561034 A JP2023561034 A JP 2023561034A JP 2023561034 A JP2023561034 A JP 2023561034A JP 2024512791 A5 JP2024512791 A5 JP 2024512791A5
Authority
JP
Japan
Prior art keywords
topical
group
wipe
weight
nifedipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512791A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/023130 external-priority patent/WO2022212892A1/en
Publication of JP2024512791A publication Critical patent/JP2024512791A/ja
Publication of JP2024512791A5 publication Critical patent/JP2024512791A5/ja
Pending legal-status Critical Current

Links

JP2023561034A 2021-04-01 2022-04-01 ニフェジピンとリドカインとを含む局所用ワイプ Pending JP2024512791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163169768P 2021-04-01 2021-04-01
US63/169,768 2021-04-01
PCT/US2022/023130 WO2022212892A1 (en) 2021-04-01 2022-04-01 Topical wipe containing nifedipine and lidocaine

Publications (2)

Publication Number Publication Date
JP2024512791A JP2024512791A (ja) 2024-03-19
JP2024512791A5 true JP2024512791A5 (cg-RX-API-DMAC7.html) 2025-04-08

Family

ID=83456873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561034A Pending JP2024512791A (ja) 2021-04-01 2022-04-01 ニフェジピンとリドカインとを含む局所用ワイプ

Country Status (8)

Country Link
US (1) US20240156756A1 (cg-RX-API-DMAC7.html)
EP (1) EP4312984A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024512791A (cg-RX-API-DMAC7.html)
CN (1) CN117377461A (cg-RX-API-DMAC7.html)
AU (1) AU2022252406A1 (cg-RX-API-DMAC7.html)
CA (1) CA3213764A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023011498A (cg-RX-API-DMAC7.html)
WO (1) WO2022212892A1 (cg-RX-API-DMAC7.html)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
JP3012732U (ja) * 1994-12-20 1995-06-27 茂郎 槇島 痔治療の薬剤保持部材
IT1297886B1 (it) * 1997-02-28 1999-12-20 Carmine Antropoli Nifedipina per uso topico
JP2001170159A (ja) * 1999-12-19 2001-06-26 Alcare Co Ltd 緩衝能を有する接皮部材
US20040167479A1 (en) * 2003-02-20 2004-08-26 The Procter & Gamble Company Hemorrhoid treatment pad
US8377459B2 (en) * 2003-07-09 2013-02-19 The Procter & Gamble Company Composition for wet wipes that enhances the efficacy of cleansing while being gentle to the skin
WO2014140925A2 (en) * 2013-03-10 2014-09-18 Peritech Pharma Ltd. Topical compositions and methods of treatment of topical disorders
PT3220924T (pt) * 2014-11-17 2022-01-12 Rev Pharma Corp Medicamento tópico para lesões da pele e mucosas associadas à epidermólise bolhosa
WO2016118040A1 (ru) * 2015-01-21 2016-07-28 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий
IT201800002413A1 (it) * 2018-02-05 2019-08-05 Carmine Antropoli "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie"
BR102018008324A2 (pt) * 2018-04-25 2019-11-05 Laboratórios Ferring Ltda. composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico
EA036752B1 (ru) * 2019-02-25 2020-12-16 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Способ получения геля для ректального и наружного применения, включающего нифедипин и лидокаина гидрохлорид (варианты)

Similar Documents

Publication Publication Date Title
US20240108569A1 (en) Transdermal compositions of ibuprofen and methods of use thereof
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
US8470886B2 (en) Topical ibuprofen formulations
US8609722B2 (en) Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
US10085939B2 (en) Composition of dexibuprofen transdermal hydrogel
US20070225379A1 (en) Transdermal delivery of systemically active central nervous system drugs
US8889155B2 (en) Gel composition for treating mycosis
US20040029946A1 (en) Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
US20130143831A1 (en) Topical pharmaceutical composition comprising flurbiprofen
KR101148470B1 (ko) 구강점막용 펜타닐 함유 패치
US20120157536A1 (en) Composition for transdermal administration of non-steroidal anti-flammatory drug
KR20100093589A (ko) 스테로이드 호르몬을 함유하는 경피성 약학적 조성물
JPWO2003105841A1 (ja) 抗真菌医薬組成物
US20100004338A1 (en) Topical gel composition comprising azelaic acid
US20090209604A1 (en) Topical combination therapy for treating acne
US12508221B2 (en) Topical compositions and methods of use
US20200338023A1 (en) Non-toxic topical formulations of dapsone
WO2016116909A2 (en) Non-staining topical gel compositions of nimesulide
FR3127689A1 (fr) Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques du membre fantôme
JPH111433A (ja) トルナフテ−ト含有液剤
KR100661871B1 (ko) 속효성의 항진균 외용약제 조성물
US20140206735A1 (en) High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosacea
JPH0242812B2 (cg-RX-API-DMAC7.html)
JP2024180190A (ja) 被膜形成性外用組成物
KR100581169B1 (ko) 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법